Skip to main content

Advertisement

SpringerLink
Log in

Selling long life

  • Feature
  • Published:

From Nature Biotechnology

View current issue Submit your manuscript

An Erratum to this article was published on 12 May 2015

A Corrigendum to this article was published on 06 February 2015

This article has been updated

A new generation of commercial entities is beginning to explore opportunities for new types of interventions and services in a graying world.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1: Going to extremes.
Figure 2: Increase in life expectancy at birth with elimination of disease.
Figure 3: Molecular targets for caloric restriction and interventions against premature aging.
Figure 4: The wellderly.

Alamy

Figure 5

Alamy

Change history

  • 14 January 2015

    In the version of this article initially published, the caption for Figure 5 read “Pope Innocent VIII, likely the first patient to undergo parabiosis.” In fact, he did not undergo parabiosis, but a blood transfusion. The caption should have read “Pope Innocent VIII died in a rejuvenation attempt in 1492.” The errors have been corrected in the HTML and PDF versions of the article.

  • 30 April 2015

    In the version of this article initially published, Retrotope Inc. was included in Table 1 in the “Walking dead” category. Nature Biotechnology has since been informed by Retrotope management that the company raised $10 million in seed funding in 2014. Retrotope has been removed from Table 1. The error has been corrected in the HTML and PDF versions of the article.

References

  1. Partridge, L. The new biology of ageing. Philos. Trans. R. Soc. Lond., B, Biol. Sci. 365, 147–154 (2010).

    Article  Google Scholar 

  2. Olshansky, S.J., Carnes, B.A. & Cassel, C. In search of Methuselah: estimating the upper limits of human longevity. Science 250, 634–640 (1990).

    Article  CAS  Google Scholar 

  3. de Cabo, R. et al. The search for antiaging interventions: from elixirs to fasting regimes. Cell 157, 1515–1526 (2014).

    Article  CAS  Google Scholar 

  4. Kenyon, C., Chang, J., Gensch, E., Rudner, A. & Tabtiang, R. A C. elegans mutant that lives twice as long as wild type. Nature 366, 461–464 (1993).

    Article  CAS  Google Scholar 

  5. Garber, K., A midlife crisis for aging theory., Nat. Biotechnol., 26, 371–374 (2008).

    Article  CAS  Google Scholar 

  6. McCay, C.M. et al. The effect of retarded growth upon the length of life span and the ultimate body size. J. Nutr. 10, 63–79 (1935).

    Article  CAS  Google Scholar 

  7. Steakley, L. An experiment that “treats each person as his or her own experiment.” Scope http://scopeblog.stanford.edu/2014/02/12/an-experiment-that-treats-each-person-as-his-or-her-own-experiment/ (12 February 2014).

    Google Scholar 

  8. Britt, R.R. Infusion of young blood revives old muscles. livesciencehttp://www.livescience.com/156-infusion-young-blood-revives-muscles.html (16 February 2005).

  9. Rochon, J. et al. Design and conduct of the CALORIE study. J. Gerontol. A Biol. Sci. Med. Sci. 66A, 97–108 (2011).

    Article  Google Scholar 

  10. Stipp, D. The Youth Pill: Scientists at the Brink of an Anti-Aging Revolution (Current, New York, 2010).

    Google Scholar 

Download references

Author information

Author notes

  1. Christopher Thomas Scott and Laura DeFrancesco: Christopher Thomas Scott is a Contributing Editor at Nature Biotechnology

Authors and Affiliations

  1. Laura DeFrancesco is a Senior Editor at Nature Biotechnology.,

    Laura DeFrancesco

Authors
  1. Christopher Thomas Scott
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Laura DeFrancesco
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Scott, C., DeFrancesco, L. Selling long life. Nat Biotechnol 33, 31–40 (2015). https://doi.org/10.1038/nbt.3108

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt.3108

  • Springer Nature America, Inc.

This article is cited by

Search

Navigation